论文部分内容阅读
目前国内对血清可溶性白介素2受体（solubleintecleuckin-2receptoc，sIL-2R）方面的研究较多。恶性肿瘤患者当出现该项指标升高时，往往提示免疫功能低下以及预后不佳。消炎痛却具有多方位的调节、增强免疫力的功能。我们对34例肺癌患者服用消炎痛前后检测SIL-ZR的含量，发现
At present, there are many studies on serum soluble interleukin 2 receptor (sIL-2R). Patients with malignant tumors, when this indicator rises, often indicate poor immune function and poor prognosis. Indomethacin has multi-directional regulation and immune enhancement. We detected the content of SIL-ZR in 34 lung cancer patients before and after taking indomethacin.